UNH vs. HUM: Which Insurance Stock Offers Greater Potential Following CMS's Reversal of Wall Street's Major Medicare Rate Concern?
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 07 2026
0mins
Source: stocktwits
Medicare Advantage Funding Increase: A revised policy is set to add over $13 billion in funding to Medicare Advantage plans, following a previous proposal that significantly impacted insurers' market value.
Stock Performance: Shares of UnitedHealth (UNH) rose by 8% and Humana (HUM) gained 11% after the announcement, although both stocks have seen declines of approximately 45% and 27% respectively over the past year.
Payment Rate Adjustments: The Centers for Medicare & Medicaid Services (CMS) finalized a 2.48% increase in Medicare Advantage payment rates for 2027, reversing earlier proposals that kept rates flat.
Market Sentiment: Retail sentiment for UNH and HUM remains bullish, with analysts providing a range of ratings, indicating a strong outlook for UnitedHealth's expanding AI strategy and potential revenue relief amidst rising medical costs.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy UNH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on UNH
Wall Street analysts forecast UNH stock price to fall
19 Analyst Rating
16 Buy
3 Hold
0 Sell
Strong Buy
Current: 405.550
Low
330.00
Averages
397.82
High
444.00
Current: 405.550
Low
330.00
Averages
397.82
High
444.00
About UNH
UnitedHealth Group Incorporated is a healthcare and well-being company. Its segments include Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, which includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State. Optum Health provides comprehensive and patient-centered care, addressing the physical, mental, and social well-being. Optum Health delivers primary, specialty and surgical care and helps patients and providers navigate and address complex, chronic and behavioral health needs. Optum Insight connects the healthcare system with services, analytics and platforms that make clinical, administrative and financial processes simpler and more efficient for all participants in the healthcare system. Optum Rx offers a range of pharmacy care services through retail pharmacies, through home delivery, specialty and community health pharmacies and the provision of in-home and community-based infusion services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Citigroup Options Trading Volume Surges
- Options Trading Volume Analysis: Citigroup Inc (C) saw an options trading volume of 56,742 contracts today, representing approximately 5.7 million underlying shares, which is about 52.8% of its average daily trading volume of 10.7 million shares over the past month, indicating strong market interest.
- Specific Options Performance: The $110 strike put option has seen a notable trading volume of 8,780 contracts today, representing approximately 878,000 underlying shares, reflecting investor expectations of a potential decline in the stock price.
- UnitedHealth Group Options Dynamics: Concurrently, UnitedHealth Group Inc (UNH) recorded an options trading volume of 35,022 contracts, equivalent to about 3.5 million underlying shares, which constitutes 50% of its average daily trading volume of 7.0 million shares over the past month, showcasing the stock's market activity.
- High Volume Options Analysis: The $410 strike call option for UNH has traded 2,397 contracts today, representing approximately 239,700 underlying shares, indicating investor confidence in the stock's potential for future appreciation.
See More
UnitedHealth Group Stock Rebounds to 52-Week High
- Financial Recovery: UnitedHealth Group reported first-quarter revenue of $111.72 billion, a 2% increase year-over-year, exceeding analysts' expectations of $109.57 billion, indicating improved cost management and boosting market confidence.
- Declining Medical Expense Ratio: The company's medical benefit ratio dropped by 90 basis points to 83.9%, reflecting progress in managing healthcare costs, which enhances profitability and investor confidence.
- Medicare Plan Adjustments: Despite scaling back Medicare Advantage plans in several states, the company served 7.55 million Medicare patients in the first quarter, down from 8.45 million a year ago, yet the Medicare and Retirement division saw a 1% revenue increase year-over-year, showcasing resilience.
- AI Technology Implementation: The launch of the generative AI chatbot Avery, which served 6.5 million members this spring and aims to expand to over 20 million by year-end, highlights the company's strategic investment in enhancing customer experience and operational efficiency.
See More
UnitedHealth Group Stock Rebounds Amid Medicare Rate Boost
- Stock Rebound: UnitedHealth Group's stock has risen 23% since the beginning of the year, although it remains down 34% from 2022, indicating market optimism, particularly following improvements in Medicare reimbursement rates.
- Financial Performance Exceeds Expectations: The company reported Q1 revenue of $111.72 billion, a 2% increase from last year, surpassing analysts' expectations of $109.57 billion, demonstrating resilience in the healthcare service sector and stable market demand.
- Improved Medical Cost Ratio: The medical benefit ratio dropped by 90 basis points to 83.9%, indicating progress in cost control, and despite scaling back Medicare Advantage plans in several states, the company still achieved slight revenue growth.
- AI Technology Implementation: The launch of the AI chatbot Avery has served 6.5 million members, with plans to expand to 20 million by year-end, reflecting the company's proactive approach to digital transformation aimed at enhancing customer experience and operational efficiency.
See More
UnitedHealth Group to Release Q2 2026 Financial Results
- Earnings Release Schedule: UnitedHealth Group will announce its Q2 2026 financial results on July 16, 2026, before market open, and will host a teleconference at 8:00 a.m. ET to discuss its financial performance and future outlook with analysts and investors.
- Webcast and Replay: The teleconference will be webcast on the company's Investor Relations page, with a replay available until July 30, 2026, ensuring that investors can access key information and conduct their analyses in a timely manner.
- Company Overview: UnitedHealth Group is a healthcare and well-being company focused on helping people live healthier lives, with its Optum division delivering care through technology and data, while UnitedHealthcare provides a full range of health benefits aimed at simplifying the healthcare experience and ensuring access to high-quality care.
- Strategic Goals: By integrating technology and data, UnitedHealth Group not only enhances the accessibility of healthcare services but also aims to create a more efficient health system through its two distinct business segments, further solidifying its leadership position in the healthcare industry.
See More
UnitedHealth Shares Hit New High Amid Analyst Upgrades
- Stock Surge: UnitedHealth (UNH) shares climbed to $413 during Tuesday's intraday session, marking a new 52-week high, reflecting Wall Street analysts' optimism as expectations rise for a more predictable regulatory environment in the health insurance sector, which could drive stock price increases.
- Price Target Increases: JPMorgan raised its price target on UNH from $420 to $466 while maintaining an 'Overweight' rating, and Mizuho increased its target from $440 to $460, indicating a growing confidence among analysts in the company's fundamentals.
- Dividend Growth: Applied Materials (AMAT) shares reached a new high of $525.98 after announcing a quarterly dividend, with the board approving a $0.53 per share payout, marking the ninth consecutive annual increase and reflecting sustained demand driven by AI advancements.
- Rising Revenue Expectations: Citigroup (C) shares surged to $135.93 after the CFO indicated strong performance across markets and investment banking, with expectations for market revenue to increase by a high-single-digit to low-double-digit percentage, further bolstering confidence in the bank's turnaround strategy.
See More
Global Economic and Market Dynamics
- Middle East Tensions: The conflict between Israel and Iran escalates as Trump calls for an immediate ceasefire, which could jeopardize the fragile ceasefire established in April, further destabilizing the region and impacting global market sentiment.
- Market Volatility: On Friday, the Nasdaq Composite plummeted over 4%, marking its largest single-day drop since April 2025, primarily driven by a collapse in chip stocks and surging Treasury yields, indicating a sharp shift in market sentiment.
- Aviation Industry Competition: Delta Air Lines' new president, Peter Carter, aims to challenge United Airlines' dominance in trans-Pacific routes, with Delta reporting a net profit of $2.79 billion last year, still trailing United's $6.89 billion, highlighting intense market competition.
- Coffee Market Challenge: Italian coffee giant Lavazza launches its espresso tablets in the U.S., with North American revenue rising nearly 27% last year, yet it still faces significant challenges in catching up to Keurig's market leadership, potentially disrupting the single-serve coffee segment.
See More
Citigroup Options Trading Volume Surges
- Options Trading Volume Analysis: Citigroup Inc (C) saw an options trading volume of 56,742 contracts today, representing approximately 5.7 million underlying shares, which is about 52.8% of its average daily trading volume of 10.7 million shares over the past month, indicating strong market interest.
- Specific Options Performance: The $110 strike put option has seen a notable trading volume of 8,780 contracts today, representing approximately 878,000 underlying shares, reflecting investor expectations of a potential decline in the stock price.
- UnitedHealth Group Options Dynamics: Concurrently, UnitedHealth Group Inc (UNH) recorded an options trading volume of 35,022 contracts, equivalent to about 3.5 million underlying shares, which constitutes 50% of its average daily trading volume of 7.0 million shares over the past month, showcasing the stock's market activity.
- High Volume Options Analysis: The $410 strike call option for UNH has traded 2,397 contracts today, representing approximately 239,700 underlying shares, indicating investor confidence in the stock's potential for future appreciation.
See More
UnitedHealth Group Stock Rebounds to 52-Week High
- Financial Recovery: UnitedHealth Group reported first-quarter revenue of $111.72 billion, a 2% increase year-over-year, exceeding analysts' expectations of $109.57 billion, indicating improved cost management and boosting market confidence.
- Declining Medical Expense Ratio: The company's medical benefit ratio dropped by 90 basis points to 83.9%, reflecting progress in managing healthcare costs, which enhances profitability and investor confidence.
- Medicare Plan Adjustments: Despite scaling back Medicare Advantage plans in several states, the company served 7.55 million Medicare patients in the first quarter, down from 8.45 million a year ago, yet the Medicare and Retirement division saw a 1% revenue increase year-over-year, showcasing resilience.
- AI Technology Implementation: The launch of the generative AI chatbot Avery, which served 6.5 million members this spring and aims to expand to over 20 million by year-end, highlights the company's strategic investment in enhancing customer experience and operational efficiency.
See More
UnitedHealth Group Stock Rebounds Amid Medicare Rate Boost
- Stock Rebound: UnitedHealth Group's stock has risen 23% since the beginning of the year, although it remains down 34% from 2022, indicating market optimism, particularly following improvements in Medicare reimbursement rates.
- Financial Performance Exceeds Expectations: The company reported Q1 revenue of $111.72 billion, a 2% increase from last year, surpassing analysts' expectations of $109.57 billion, demonstrating resilience in the healthcare service sector and stable market demand.
- Improved Medical Cost Ratio: The medical benefit ratio dropped by 90 basis points to 83.9%, indicating progress in cost control, and despite scaling back Medicare Advantage plans in several states, the company still achieved slight revenue growth.
- AI Technology Implementation: The launch of the AI chatbot Avery has served 6.5 million members, with plans to expand to 20 million by year-end, reflecting the company's proactive approach to digital transformation aimed at enhancing customer experience and operational efficiency.
See More
UnitedHealth Group to Release Q2 2026 Financial Results
- Earnings Release Schedule: UnitedHealth Group will announce its Q2 2026 financial results on July 16, 2026, before market open, and will host a teleconference at 8:00 a.m. ET to discuss its financial performance and future outlook with analysts and investors.
- Webcast and Replay: The teleconference will be webcast on the company's Investor Relations page, with a replay available until July 30, 2026, ensuring that investors can access key information and conduct their analyses in a timely manner.
- Company Overview: UnitedHealth Group is a healthcare and well-being company focused on helping people live healthier lives, with its Optum division delivering care through technology and data, while UnitedHealthcare provides a full range of health benefits aimed at simplifying the healthcare experience and ensuring access to high-quality care.
- Strategic Goals: By integrating technology and data, UnitedHealth Group not only enhances the accessibility of healthcare services but also aims to create a more efficient health system through its two distinct business segments, further solidifying its leadership position in the healthcare industry.
See More
UnitedHealth Shares Hit New High Amid Analyst Upgrades
- Stock Surge: UnitedHealth (UNH) shares climbed to $413 during Tuesday's intraday session, marking a new 52-week high, reflecting Wall Street analysts' optimism as expectations rise for a more predictable regulatory environment in the health insurance sector, which could drive stock price increases.
- Price Target Increases: JPMorgan raised its price target on UNH from $420 to $466 while maintaining an 'Overweight' rating, and Mizuho increased its target from $440 to $460, indicating a growing confidence among analysts in the company's fundamentals.
- Dividend Growth: Applied Materials (AMAT) shares reached a new high of $525.98 after announcing a quarterly dividend, with the board approving a $0.53 per share payout, marking the ninth consecutive annual increase and reflecting sustained demand driven by AI advancements.
- Rising Revenue Expectations: Citigroup (C) shares surged to $135.93 after the CFO indicated strong performance across markets and investment banking, with expectations for market revenue to increase by a high-single-digit to low-double-digit percentage, further bolstering confidence in the bank's turnaround strategy.
See More
Global Economic and Market Dynamics
- Middle East Tensions: The conflict between Israel and Iran escalates as Trump calls for an immediate ceasefire, which could jeopardize the fragile ceasefire established in April, further destabilizing the region and impacting global market sentiment.
- Market Volatility: On Friday, the Nasdaq Composite plummeted over 4%, marking its largest single-day drop since April 2025, primarily driven by a collapse in chip stocks and surging Treasury yields, indicating a sharp shift in market sentiment.
- Aviation Industry Competition: Delta Air Lines' new president, Peter Carter, aims to challenge United Airlines' dominance in trans-Pacific routes, with Delta reporting a net profit of $2.79 billion last year, still trailing United's $6.89 billion, highlighting intense market competition.
- Coffee Market Challenge: Italian coffee giant Lavazza launches its espresso tablets in the U.S., with North American revenue rising nearly 27% last year, yet it still faces significant challenges in catching up to Keurig's market leadership, potentially disrupting the single-serve coffee segment.
See More
